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Abstract 
 Translation is an essential cellular process, resulting in the synthesis of proteins (1). 
While translation is critical for the cell, it is comparatively error-prone relative to other essential 
cellular processes. In translation, errors occur approximately once per 104 codons. In 
comparison, the error rate in DNA replication is approximately one error per 108 nucleotides (1). 
It is important to understand how these errors in translation affect the cell. Aminoacyl-tRNA 
synthetases (aaRSs) are critical enzymes in translation which ligate tRNA to their cognate 
amino acids. Due to their ability to edit tRNA mischarged with non-cognate amino acids through 
pre- and post-transfer editing, aaRSs have a role in prevention of errors in translation (1). A lack 
of aaRS quality control has been shown to be detrimental to the cell (2, 3). While aaRS quality 
control can be important for the cell, it has been observed that certain aaRSs can mischarge 
tRNA with non-cognate amino acids. Alanyl-tRNA synthetase (AlaRS) from Streptococcus 
pneumoniae, a Gram-positive organism, mischarges tRNAAla with serine. Ser-tRNAAla has been 
shown to be used by MurM, an enzyme involved in peptidoglycan crosslinking in S. pneumoniae 
(6). To further study AlaRS quality control in Gram-positive organisms, an AlaRS editing 
deficient Bacillus subtilis strain was made. B. subtilis alaS, which encodes for AlaRS, was 
cloned into pET28a, and mutagenized to encode C668A AlaRS (8). B. subtilis wild-type (WT) 
and C668A AlaRS were expressed and purified for characterization in vitro to confirm that the 
C668A mutation diminished AlaRS editing activity. WT and C668A AlaRS were able to charge 
tRNAAla with alanine. However, C668A AlaRS was able to mischarge tRNAAla with serine, and 
had a diminished ability to edit Ser-tRNAAla compared to WT AlaRS. This suggests that C668 is 
an essential residue for AlaRS editing activity. Lastly, there was no significant difference in 
growth between the WT and AlaRS editing deficient B. subtilis strains in Luria Broth (LB) or M9 
minimal media, which suggests that AlaRS quality control is not required for normal growth in 
these conditions. 
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Introduction 
Translation is an essential cellular process, resulting in the synthesis of proteins. While 
translation is a critical cellular process, errors occur more frequently in translation than in other 
processes in the cell. The error rate of translation is approximately one error per 104 codons, 
while the error rate of DNA replication is approximately one error per 108 nucleotides (1). Since 
translation is a comparatively error prone cellular process, it is important to understand the 
effects of these errors on the cell. 
 Aminoacyl-tRNA synthetases (aaRSs) have an important role in translation; aaRSs 
attach amino acids to their cognate tRNAs (Figure 1). These enzymes are critical in the 
prevention of errors during protein synthesis, due to their ability to discriminate between cognate 
and non-cognate amino acids (1, 2). Since certain amino acids are structurally similar, aaRSs 
can perform pre- and post-transfer editing, to remove non-cognate amino acids from the aaRS 
or tRNA (Figure 2). The editing capabilities of aaRSs prevent errors in translation and highlight 
their importance in translational quality control (1, 2). 
 
Figure 1: Aminoacyl-tRNA synthetases attach amino acids to the cognate tRNA, in a two-step reaction, 
resulting in ester bond formation. First, the amino acid and ATP are attached to the aaRS; ATP is required 
to generate the aminoacyl adenylate. Then, the amino acid is attached to tRNA, which results in an 
aminoacyl-tRNA (1).  
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Figure 2: AaRSs are critical in maintaining fidelity in translation because some aaRSs have editing 
mechanisms to prevent the misincorporation of non-cognate amino acids into proteins. Pre-transfer editing 
results in the removal of a non-cognate amino acid from the active site of the aaRS; post-transfer editing 
leads to separation of a non-cognate amino acid from a tRNA (modified from 1). 
 
 
 AaRSs have an important role in preventing errors in translation, and a lack of aaRS 
quality control has been documented to be detrimental to the cell in both bacteria and 
eukaryotes. For instance, there is evidence that phenylalanyl-tRNA synthetase (PheRS) quality 
control is important for the growth of Escherichia coli during oxidative stress, where there is an 
increased concentration of meta-Tyrosine (m-Tyr). A PheRS editing deficient E. coli strain, 
unable to edit m-Tyr-tRNAPhe, had decreased growth compared to a wild-type (WT) strain in the 
presence of hydrogen peroxide, which increased the concentration of m-Tyr in the cell (2). In 
Saccharomyces cerevisiae, PheRS quality control was shown to be important for the Target of 
Rapamycin (TOR) pathway, which is responsible for sensing cellular nitrogen availability and 
responding appropriately. A PheRS editing deficient S. cerevisiae strain had decreased activity 
of Gln3p, a transcription factor involved in the TOR pathway, compared to a WT strain when 
grown in ammonium (3). Additionally, neurodegeneration of Purkinje cells was documented in 
mice with an editing defective alanyl-tRNA synthetase (AlaRS), due increased amount of 
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misfolded proteins (4). These examples provide evidence that aaRS quality control is important 
for cellular viability across all domains of life. 
While there are many conditions where aaRS quality control is required, there is also 
evidence that mistranslation can be beneficial to the cell. For example, in Candida albicans, a 
lack of translational quality control, leading to increased leucine misincorporation, benefits the 
cell because it can result in new proteins. It can also generate a stress response, aiding in 
survival in the presence of harmful compounds such as hydrogen peroxide (1). Moreover, 
increased misincorporation of methionine occurs in mammalian cells under high concentrations 
of reactive oxygen species (ROS), when pathogens are detected. Under these conditions, 
mistranslation is beneficial because methionine decreases the damage sustained by cells 
during oxidative stress (1). This evidence suggests that mistranslation is not always harmful to 
cells.  
Despite the fact that aaRSs can help maintain fidelity during translation, aaRSs have 
also been shown to mischarge tRNA, which can lead to mistranslation. It has been documented 
that WT Streptococcus pneumoniae isoleucyl-tRNA synthetase (IleRS) can form Val-tRNAIle and 
Leu-tRNAIle. However, E. coli IleRS was not able to mischarge tRNAIle with valine and leucine to 
the same extent as the S. pneumoniae enzyme (5). Moreover, S. pneumoniae AlaRS has been 
shown to mischarge tRNAAla with serine and glycine, which may have additional ramifications in 
the cell (6). In S. pneumoniae, a Gram-positive bacterium, MurM is involved in peptidoglycan 
crosslinking; this enzyme is partially responsible for branching of alanine-alanine or serine-
alanine from the stem peptide (6). Mischarged Ser-tRNAAla has been shown to be used by 
MurM with a higher efficiency than tRNAAla charged with the cognate amino acid, alanine. MurM 
is also important in S. pneumoniae resistance to penicillin (6). The roles of AlaRS mischarging 
of tRNAAla and peptidoglycan crosslinking on penicillin resistance merits further study.  
To continue to investigate the role of AlaRS quality control in another Gram-positive 
bacterium and compare this to Gram-negative bacteria (7), an AlaRS editing deficient B. subtilis 
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strain was made. First, B. subtilis alaS, which encodes for AlaRS, was cloned into pET28a (8). 
Since a C666A substitution has been shown to decrease editing activity in E. coli AlaRS, E. coli 
and B. subtilis AlaRS amino acid sequences were aligned; it was determined that C668 was the 
homologous residue in B. subtilis AlaRS (9). alaS was mutagenized to encode C668A AlaRS. B. 
subtilis WT and C668A AlaRS were isolated using His-tag protein purifications. B. subtilis 
C668A AlaRS was compared in vitro to WT AlaRS to ensure that this mutation diminished 
editing activity. It was found that the C668A substitution did not affect aminoacylation of tRNAAla 
with alanine, the cognate amino acid. However, the C668A substitution significantly increased 
mischarging of tRNAAla with serine, a non-cognate amino acid, compared to WT AlaRS. C668A 
AlaRS also showed decreased editing activity of Ser-tRNAAla compared to WT AlaRS. To study 
the effects of AlaRS quality control in vivo, an AlaRS editing deficient strain of B. subtilis was 
made. C668A alaS was inserted into the chromosome of B. subtilis using pMiniMad2 allelic 
replacement. When grown in Luria Broth (LB) and M9 Minimal Media, there were no significant 
differences between the WT and AlaRS editing deficient B. subtilis strains. Additionally, the 
growth of WT and AlaRS editing deficient B. subtilis strains in M9 minimal media with addition of 
0.5 mM or 5 mM serine were compared.  
 
Results 
Determining a mutation to eliminate B. subtilis AlaRS editing activity 
First, a mutation to decrease the editing activity of B. subtilis AlaRS was identified. It has 
been previously documented that a C666A substitution in E. coli AlaRS leads to mischarging of 
Ser-tRNAAla and Gly-tRNAAla and decreases the enzyme’s ability to edit mischarged tRNAAla (9). 
To determine if there was a homologous residue to C666 in B. subtilis AlaRS, B. subtilis and E. 
coli AlaRS protein sequences were aligned using Protein BLAST NCBI (Figure 3). While the 
sequences were only 45% identical, C668 in B. subtilis AlaRS aligned with E. coli C666 and 
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surrounding residues. Site-directed mutagenesis was used to induce a missense mutation in B. 
subtilis alaS to encode the substitution C668A. 
 
Figure 3: Alignment of E. coli (Query) and B. subtilis (Subject) AlaRS amino acid sequences. The 
homologous cysteine residues being compared, C666 in E. coli AlaRS and C668 in B. subtilis AlaRS, are 
boxed in blue. 
 
Cloning and Purification of B. subtilis WT and C668A AlaRS  
The gene which encodes for AlaRS, alaS, was PCR amplified from B. subtilis genomic 
DNA, inserted into pET28a and transformed into BL21(DE3) E. coli after the insertion was 
confirmed with Sanger sequencing (8). Then, a missense mutation encoding C668A AlaRS was 
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introduced into alaS using site-directed mutagenesis. pET28a alaS was used as the template 
DNA plasmid. After confirmation of the mutation with Sanger sequencing, pET28a C668A alaS 
was transformed into BL21(DE3) E. coli.  
 His-tag protein purifications were used to isolate B. subtilis WT and C668A AlaRS for 
characterization in vitro. E. coli containing pET28a alaS or C668A alaS were grown to an OD600 
of 0.3-0.6. 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the cultures to 
induce expression of alaS in pET28a. The cells were grown for an additional four hours and 
then pelleted. After sonication to lyse the cells and centrifugation, Talon metal affinity columns 
were used to purify AlaRS. SDS-PAGE gels (Figures 4 and 5) were used to assess the 
presence and purity of AlaRS isolated in the elution fractions. According to UniProt, B. subtilis 
AlaRS is about 97 kDa; therefore, the isolated protein should run at about 100 kDa on an SDS-
PAGE gel. In the elution fractions for both WT (Figure 4) and C668A (Figure 5) AlaRS, there 
was a thick band at approximately 100 kDa. Active site titrations were used to assess activity of 
WT and C668A AlaRS by monitoring formation of the aminoacyl adenylate. WT AlaRS was 
found to be approximately 162.6 µM active, while C668A AlaRS was found to be approximately 
342.6 µM active.  
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Figure 4: SDS-PAGE gel from the His-tag purification of B. subtilis WT AlaRS. From left to right, BioRad 
Precision Plus Protein Standards Kaleidoscope ladder, pre-induction, post-induction, pellet, lysate, flow 
through (FT), wash and elution fractions 1-8. B. subtilis AlaRS is approximately 97 kDa (UniProt). Elution 
fractions 1-6 were combined and dialyzed to isolate AlaRS. 
 
 
Figure 5: SDS-PAGE gel from the His-tag purification of C668A AlaRS. From left to right, NEB Protein (10-
200 kDa) ladder, pre-induction, post-induction, pellet, lysate, FT, wash and elution fractions 1-8. B. subtilis 
AlaRS is approximately 97 kDa (UniProt), and expected to run approximately the same distance as the 100 
kDa marker. Elution fractions 1-5 were combined and dialyzed to isolate C668A AlaRS. 
 
B. subtilis WT and C668A AlaRS charge B. subtilis tRNAAla with alanine 
	 Both WT and C668A B. subtilis AlaRS were able to charge tRNAAla with alanine, the 
cognate amino acid (Figure 6). This suggests that the C668A substitution does not affect the 
mutant enzyme’s active site, since it is still able to aminoacylate tRNAAla. Moreover, this 
suggests that the C668 residue is not essential for the generation of Ala-tRNAAla. It is important 
that C668A AlaRS is still able to efficiently charge tRNAAla with its cognate tRNA to solely 
determine the effects of AlaRS mischarging of tRNAAla with non-cognate amino acids in B. 
subtilis. The inability to charge tRNAAla with alanine may cause different effects in the cell than 
the mischarging of tRNAAla.  
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Figure 6: Aminoacylation of B. subtilis tRNAAla with 14C-alanine by B. subtilis WT (blue) and C668A (red) 
AlaRS determined by aminoacylation assays. Time points were taken at 0 (before addition of enzyme), 5, 
15, 30 and 60 minutes. Triplicates were performed and averaged for each enzyme. Error bars represent 
the standard deviation of the triplicates at each time point.  
 
B. subtilis C668A AlaRS mischarges tRNAAla with serine 
B. subtilis C668A AlaRS mischarges tRNAAla with serine, a non-cognate amino acid 
(Figure 7). B. subtilis WT AlaRS does not mischarge tRNAAla with serine (Figure 7), indicating its 
ability to discriminate between the cognate and non-cognate amino acids for tRNAAla and 
prevent accumulation of mischarged tRNA. The concentration of Ser-tRNAAla charged by B. 
subtilis WT AlaRS is similar to the negative control (Figure 7). This indicates that the C668A 
substitution diminishes the enzyme’s ability to properly discriminate between alanine and serine, 
leading to a high concentration of Ser-tRNAAla formed. Additionally, this suggests the 
importance of the C668 residue in AlaRS quality control and prevention of mischarging of 
tRNAAla with serine. 
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Figure 7: Misacylation of B. subtilis tRNAAla with 3H-serine by B. subtilis WT (blue) and C668A (red) AlaRS 
over time. Time points were taken at 0 (before addition of enzyme), 5, 15, 30 and 60 minutes. Triplicates 
were performed for each enzyme and averaged. Error bars on the graph represent the standard deviation 
of the triplicates each time point. Additionally, one experiment was performed without addition of either 
enzyme as a negative control (black). 
 
B. subtilis C668A AlaRS has diminished ability to edit mischarged Ser-tRNAAla 
B. subtilis C668A AlaRS has a diminished ability to edit tRNAAla mischarged with serine, 
and is similar to the no enzyme control (Figure 8). B. subtilis WT AlaRS is able to edit Ser-
tRNAAla that has been mischarged, leading to the hydrolysis of the bond between serine and 
tRNAAla (Figure 8). When comparing the concentrations of Ser-tRNAAla remaining at the end of 
the reactions, it is evident that B. subtilis C668A AlaRS is unable to edit and hydrolyze the non-
cognate amino acid from tRNAAla at the same level as WT AlaRS (Figure 8). This suggests the 
importance of the C668 residue in the ability of AlaRS to edit mischarged tRNAAla.  
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Figure 8: Editing of preformed 3H-Ser-tRNAAla by B. subtilis WT (blue) and C668A (red) AlaRS. Time points 
were taken at 0 (before enzyme addition), 1, 3, 5, 7, 10, 20 and 30 minutes. Experiments for each enzyme 
were performed in triplicate. Error bars represent the standard deviation between each replicate at that time 
point. A negative control without enzyme was also performed (black).  
 
AlaRS quality control is not required for viability of B. subtilis in LB or M9 Minimal Media 
When grown in LB, there was no significant difference in growth between the WT and 
AlaRS editing deficient B. subtilis strains (Figure 9A). This suggests that AlaRS quality control is 
not required for growth of B. subtilis in LB. Additionally, there was no significant difference 
between the growth of the WT and AlaRS editing deficient B. subtilis strains in M9 minimal 
media (Figure 9B); this provides evidence that AlaRS quality control is also not required for 
growth of B. subtilis in M9 minimal media.  
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Figure 9: Growth in LB (A) and M9 minimal media (B) of WT and AlaRS editing deficient strains of B. 
subtilis. Overnight cultures were back diluted to a final OD600 of 0.1. Absorbance readings (OD600) of each 
culture were taken every hour for seven hours (in LB) or nine hours (in M9 minimal media). Biological 
triplicates were grown for each strain, and the OD600 measurements were averaged. Error bars represent 
the standard deviation of the OD600 measurements at each time point.  
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WT vs. AlaRS Editing Deficient B. subtilis in M9 Minimal Media with Excess Serine 
 WT and AlaRS editing deficient B. subtilis strains were grown in M9 minimal media with 
addition of 0.5 mM or 5 mM serine. After nine hours of growing at 37oC, there was not a 
significant difference in the average absorbance (OD600) between the two strains in either 0.5 
mM or 5 mM serine (Figure 10). However, the difference in growth between the WT and AlaRS 
editing deficient B. subtilis strains in 0.5 mM serine, where the average absorbance (OD600) of 
the AlaRS editing deficient strain is slightly less than the WT strain, is trending toward serine 
sensitivity. A concentration of excess serine that inhibits the growth of the AlaRS editing 
deficient strain more significantly than the WT strain of B. subtilis still needs to be determined. 
 
Figure 10:  Absorbance (OD600) of WT and AlaRS editing deficient strains of B. subtilis after 9 hours of 
growth at 37oC in M9 minimal media + excess serine (0 mM, 0.5 mM and 5 mM).  
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Discussion 
A key function of some aaRSs, including AlaRS, is their ability to recognize mischarged 
tRNA and remove the non-cognate amino acid to prevent its misincorporation into proteins 
(1,10). Since this is a critical role of AlaRS, it is important to understand how lacking AlaRS 
quality control affects different organisms. To study the role of AlaRS quality control in B. 
subtilis, an AlaRS editing deficient strain was made.  
A mutation, C668A, was made in B. subtilis alaS to encode for an AlaRS enzyme that 
had deficient editing activity. This mutation was based on a previously documented C666A 
AlaRS mutant with decreased editing function in E. coli AlaRS (9). B. subtilis C668A AlaRS was 
tested in vitro to determine if the mutation decreased editing before making a genomic mutant 
with the same mutation. It was determined that the C668A substitution did not hinder the ability 
of AlaRS to charge tRNAAla with alanine, when compared to WT AlaRS. It was essential that the 
mutation did not disrupt aminoacylation of the cognate amino acid, to allow the study of the 
effects of lacking AlaRS editing activity in B. subtilis.  
C668A AlaRS was able to mischarge tRNAAla with serine significantly more than WT 
AlaRS. Additionally, C668A AlaRS had decreased editing of mischarged Ser-tRNAAla compared 
to WT AlaRS. This provides evidence that the C668A mutation disrupts the ability of AlaRS to 
edit non-cognate amino acids from tRNAAla, without hindering its ability to charge Ala-tRNAAla. 
These results suggest that C668 is a critical residue for AlaRS editing activity in B. subtilis. 
When this cysteine residue is substituted with alanine, substantial Ser-tRNAAla mischarging 
occurs and there is diminished editing of mischarged tRNA. 
After confirmation that this mutation disrupted AlaRS editing function, C668A alaS was 
inserted into the chromosome of B. subtilis using pMiniMad2 allelic replacement to make a 
AlaRS editing deficient strain. This allowed testing in vivo of how lacking AlaRS quality control 
affects the organism. Previously, a AlaRS editing deficient E. coli strain was shown to have 
substantial growth deficiencies compared to a WT strain in LB and with increasing excess 
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serine; there was also a slight growth defect observed in the AlaRS editing deficient E. coli 
strain in minimal media (Paul Kelly, unpublished data). However, the AlaRS editing deficient 
strain of B. subtilis did not have growth defects compared to a WT strain in LB or M9 minimal 
media. This suggests possible differences in the roles of AlaRS quality control in Gram-positive 
and Gram-negative organisms that should be further explored. 
Now that a AlaRS editing deficient B. subtilis strain has been made, the effects of lacking 
AlaRS editing activity can be investigated in vivo. In the future, serine sensitivity growth assays 
can be done to determine which concentration of non-cognate amino acid, if any, inhibits the 
growth of the editing deficient strain more significantly than the WT strain. Neither a 0.5 mM nor 
5 mM serine addition led to significant differences in growth between the two strains. 
Additionally, the role of AlaRS quality control in sporulation can be studied by comparing 
sporulation in the WT and AlaRS editing deficient strains; it has been shown that IleRS editing 
activity in B. subtilis is important for sporulation (7). Lastly, since it was previously found that 
mischarged Ser-tRNAAla is used more efficiently than tRNAAla charged with alanine by MurM in 
S. pneumoniae, a Gram-positive organism, the role of AlaRS quality control in peptidoglycan 
synthesis of other Gram-positive organisms, such as B. subtilis (6, 7) should be further 
explored.  
 
Methods 
Alignment of E. coli AlaRS and B. subtilis AlaRS protein sequences  
 Amino acid sequences of E. coli and B. subtilis AlaRS were obtained from UniProt and 
aligned using Protein BLAST NCBI.  
 
Insertion of B. subtilis alaS into pET28a 
Using the polymerase chain reaction (PCR), B. subtilis alaS was amplified from genomic 
DNA. The primers (5’-GCCGCGCGGCAGCCATATGAAACACTTAACTTCTGCGGAAGTG-3’, 
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5’-TGGTGGTGGTGGTGCTTATAAAACGGATTTCACCCAATCTTCTACAG-3’) used for PCR 
generated overhang regions at the ends of alaS, to allow subsequent insertion into pET28a. The 
presence and size of PCR product was confirmed using 0.8% agarose gel electrophoresis. 
Restriction enzymes XhoI and NdeI were used to digest pET28a. Success of the restriction 
digest was confirmed using agarose gel electrophoresis. Gibson assembly was used to insert 
alaS into pET28a. The Gibson assembly reaction was transformed into XLIBlue E. coli and the 
cells were plated onto a LB + 25 µg/mL kanamycin (kan) agar plate. Plasmids were purified 
from candidates and screened for the alaS insertion using a BlpI restriction digest. The insertion 
of alaS into pET28a was confirmed with Sanger Sequencing using T7 and T7-Term primers 
from GENEWIZ. This plasmid was transformed into BL21(DE3) E. coli and the cells were plated 
onto a LB + 25 µg/mL kan agar plate.  
 
Site-directed mutagenesis of B. subtilis alaS  
Site-directed mutagenesis was used to mutate alaS. pET28a alaS was purified from 
BL21(DE3) E. coli and used as the template DNA for this reaction. The primers (5’-
GATTACAGCTTAGAGCTGGCCGGCGGCTGCCACGTCAG-3’, 5’-
CTGACGTGGCAGCCGCCGGCCAGCTCTAAGCTGTAATC-3’) were designed to mutate 
nucleotides 2002 and 2003 from TG to GC. This mutation results in the amino acid substitution 
C668A. After QuikChange site-directed mutagenesis, DpnI was added to cleave the template 
plasmid. The product was transformed into XLIBlue E. coli and plated onto a LB + 25 µg/mL kan 
agar plate. The presence of the mutation was confirmed using Sanger sequencing with a primer 
(5’-CTCATGTCAATCAGGCGGGC-3’). pET28a C668A alaS was transformed into BL21(DE3) 
E. coli.  
 
Purification of B. subtilis WT and C668A AlaRS  
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B. subtilis WT and C668A AlaRS were purified using His-tag protein purification. First, 
BL21(DE3) E. coli cells containing either pET28a alaS or pET28a C668A alaS were grown until 
an OD600 of 0.3-0.6 in LB + 25 µg/mL kan. 1mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
was added to the culture to induce the expression of pET28a. After four hours, the cells were 
pelleted and stored at -80oC. The pellet was resuspended in buffer (25 mM Tris, 300 mM NaCl, 
10% v/v Glycerol and 5 mM Imidazole). Sonication was used to lyse the cells, using four sets of 
three 10 second pulses. After centrifugation at 22,000 g for 30 minutes at 4oC twice, the lysate 
was loaded on a Talon metal affinity resin column. The column was washed with buffer (25 mM 
Tris, 300 mM NaCl, 10% v/v Glycerol and 5 mM Imidazole) and the protein was eluted with 
buffer and 250 mM imidazole in 1 mL fractions. Purity of the fractions and presence of target 
protein were assessed using SDS-PAGE gel electrophoresis. Fractions of protein were 
combined, concentrated using centrifugation and dialyzed. Activity of B. subtilis WT and C668A 
AlaRS were determined using active site titration assays with 14C-alanine. 
 
Active Site Titration 
100 mM Na2+ HEPES (pH 7.2), 30 mM KCl, 10 mM MgCl2, 5 mM ATP, 1 µg 
pyrophosphatase, 100 µM 14C-Ala and 5 µL AlaRS or storage buffer (negative control) were 
combined and incubated at 37oC for 10 minutes. Three reactions per enzyme were performed: 
no enzyme, 1:10 dilution of AlaRS and 1:50 dilution of AlaRS. Protran BA 85 filters were 
washed with buffer (50 mM Na2+ HEPES (pH 7.2), 15 mM KCl, 5 mM MgCl2) over a vacuum 
manifold. After incubation, the 50 µL reactions were placed on separate filters which were rinsed 
with buffer three additional times. The filters were dried and placed in a scintillation counter to 
quantify the concentration of 14C-Ala present in each sample.  
 
Purification of B. subtilis tRNAAla  
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Two primers were designed using a sequence of B. subtilis tRNAAla and the T7 promoter 
for T7 RNA polymerase. Equal concentrations of these primers (5’-
CGAAATTAATACGACTCACTATAGGGGCCTTAGCTCAGCTGGGAGAGCGCCTGCTTTGCA
CGCAGGAGGTCAGCGGTTCGATCCCGCTAGGCTCCACCA-3’, 5’-
TGGTGGAGCCTAGCGGGATCGAACCGCTGACCTCCTGCGTGCAAAGCAGGCGCTCTC-3’) 
were combined and were ligated together at 100oC for two minutes. The reaction was slowly 
cooled to 25oC. This ligation product was amplified using PCR with primers (5’-
CGAAATTAATACGAC-3’, 5’-TGGTGGAGCCTAGCGGGATCG-3’). The resulting PCR product 
was purified using NucleoSpin Gel and PCR Clean-up Kit.  
This purified PCR product was used as the template DNA for an in vitro transcription. 40 
mM Tris (pH 8.0), 2 mM spermidine, 22 mM MgCl2, 5 mM DTT, 50 µg/mL Bovine Serum 
Albumin (BSA), 37 µg/mL T7 RNA polymerase, 20 mM 5’ Guanosine monophosphate (GMP), 5 
µg pyrophosphatase, 4 mM NTPs, RNase inhibitor and template DNA were combined and 
incubated at 42oC overnight. To purify the in vitro transcription reaction, column purification of 
tRNA was used. The reaction was loaded onto a DEAE sephacel resin column, which was 
washed and the product was eluted with 1M NaCl. A nanodrop was used to determine the 
concentration of RNA in these fractions. Fractions were combined and tRNA was isolated using 
sodium acetate and ethanol precipitation. The concentration of tRNA was assessed using a 
nanodrop. An aminoacylation assay using B. subtilis WT AlaRS and 14C-alanine was used to 
determine the active concentration of tRNAAla. 
 
In vitro aminoacylation assays  
To monitor [Ala-tRNAAla] and [Ser-tRNAAla] charged over time by WT and C668A AlaRS, 
in vitro aminoacylation assays were performed. 100 mM Na2+ HEPES (pH 7.2), 30 mM KCl, 10 
mM MgCl2, 2 mM ATP, 1 µg pyrophosphatase, 1 mM DTT, 15 µM B. subtilis tRNAAla, 30 µM 
14C-alanine or 300 µM 3H-serine and 0.5 µM B. subtilis WT or C668A AlaRS were incubated at 
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37oC for 60 minutes. During the reaction, 9 µL were spotted onto filters at 0 (before enzyme 
addition), 5, 15, 30 and 60 minutes. The filters were pre-soaked with 5% Trichloroacetic acid 
(TCA). After the reaction was complete, the filters were washed three times with 5% TCA and 
once with 95% ethanol. Lastly, the filters were dried and assessed using a scintillation counter. 
For the aminoacylation assays with serine, a negative control without enzyme was performed by 
substituting enzyme with protein storage buffer.  
 
Deacylation assay with Ser-tRNAAla  
First, 3H-Ser-tRNAAla was formed to use in the deacylation assay. 100 mM Na2+ HEPES 
(pH 7.2), 30 mM KCl, 10 mM MgCl2, 2 mM ATP, 2 µg pyrophosphatase, 1 mM DTT, 15 µM B. 
subtilis tRNAAla, 150 µM 3H-serine and 0.5 µM B. subtilis C668A AlaRS were incubated at 37oC 
for 60 minutes. Acid phenol chloroform precipitation, with subsequent sodium acetate and 
ethanol precipitation and centrifugation was used to isolate 3H-Ser-tRNAAla. Pelleted 3H-Ser-
tRNAAla was resuspended in 100 mM sodium acetate. 
 Next, the deacylation assays were performed with 3H-Ser-tRNAAla. 100 mM Na2+ HEPES 
(pH 7.2), 30 mM KCl, 10 mM MgCl2, 3H-Ser-tRNAAla, and 2.5 nM B. subtilis WT or C668A AlaRS 
were incubated for 30 minutes at 37oC. A no enzyme control was performed once using protein 
storage buffer in place of enzyme. During the reaction, 9 µL was spotted on 5% TCA pre-
soaked filters at 0 (before enzyme addition), 1, 3, 5, 7, 10, 20 and 30 minutes. The filters were 
subsequently washed with 5% TCA three times and 95% ethanol once. The filters were dried 
and assessed via a scintillation counter.  
 
Insertion of B. subtilis C668A alaS into pMiniMad2 
pMiniMad2 was digested with SmaI and the success of the reaction was confirmed with 
agarose gel electrophoresis. B. subtilis C668A alaS was PCR amplified with overhang regions 
for pMiniMad2 using pET28a C668A alaS as the template DNA and primers (5’-
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ACTCTAGAGGATCCCCATGAAACACTTAACTTCTGC-3’, 5’-
TCGAGCTCGGTACCCTTATAAAACGGATTTCACCCA-3’). Gibson assembly was used to 
ligate C668A alaS and pMiniMad2. This reaction was transformed into XLIBlue E. coli and 
plated onto a LB + 100 µg/mL ampicillin (amp) agar plate. The plasmids from the candidates 
were screened using a restriction digest with XhoI and subsequent agarose gel electrophoresis. 
The insertion of C668A alaS was confirmed using Sanger sequencing with primers (5’-
GCGGATAACAATTTCACACA-3’, 5’-CATCAGGCGCCATTCGC-3’). This plasmid was 
transformed XLIBlue and TGI E. coli.  
 
Transformation of pMiniMad2 + C668A alaS into B. subtilis 
A colony of competent (ComI Q12L) B. subtilis was grown at 37oC for 4.5 hours in 1x MC 
media (100 mM K2HPO4l3H2O, 100 mM KH2PO4, 2% glucose, 3 mM trisodium citrate, 22 mg/L 
ferric ammonium citrate, 0.1% casein hydrolysate, 0.2% potassium glutamate). pMiniMad2 
C668A alaS, isolated from TGI E. coli, was transformed into B. subtilis at a 1:100 ratio plasmid: 
culture. The culture was grown for 2.0 hours at 37oC and then plated on a MLS (25 µg/mL 
lincomycin and 1 µg/mL erythromycin) agar plate.  
 
Allelic replacement of WT alaS with C668A alaS to make B. subtilis genomic mutant  
 pMiniMad2 C668A alaS was transformed into B. subtilis as described above and plated 
on a MLS agar plate. Then, the resulting colonies were streaked on MLS agar plates and grown 
overnight at 37oC. One of the colonies from the MLS plates was used to inoculate 3 mL LB. This 
culture was grown at 25oC overnight. The next day, this culture was diluted, plated on LB and 
these plates were incubated at 37oC. 100 of these colonies were patched onto LB and then 
MLS agar plates, which were grown at 37oC overnight. The plates were screened for colonies 
which could grow on LB, but could not grow on MLS agar plates. Genomic DNA was purified 
from MLS sensitive colonies using Wizard Genomic DNA Purification kit. alaS was PCR 
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amplified from the genome with primers (5’-
GCCGCGCGGCAGCCATATGAAACACTTAACTTCTGCGGAAGTG-3’, 5’-
TGGTGGTGGTGGTGCTTATAAAACGGATTTCACCCAATCTTCTACAG-3’) using genomic 
DNA of the candidates. The presence of the mutation was confirmed using Sanger sequencing 
with a primer (5’-CTCATGTCAATCAGGCGGGC-3’). The alaS mutation was subsequently 
confirmed with a colony PCR to amplify alaS using primers (5’-
ATGAAACACTTAACTTCTGCGG-3’, 5’-TTATAAACGGATTTCACCCAATCTTCTAC-3’) These 
PCR products were sent for Sanger sequencing with a primer (5’-
CTCATGTCAATCAGGCGGGC-3’).  
 
Growth analysis in LB, M9 minimal media and M9 minimal media with serine 
 The OD600 measurements for overnight cultures of either LB or M9 minimal media 
(glucose, without thiamine) of WT and AlaRS editing deficient B. subtilis strains were taken and 
the cultures were back diluted to a final OD600 of 0.1 in either LB, M9 minimal media or M9 
minimal media with addition of serine (0.5 mM or 5 mM). OD600 measurements were taken for 
each culture after inoculation and each hour after for 7-9 hours.  
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